What is the latest ROSSARI stock price?
The latest stored price for ROSSARI is Rs 437.95 as of 2026-09-18.
gimli
ROSSARI stock AI analysis
ROSSARI Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
ROSSARI BIOTECH LIMITED is a small-cap stock in Chemicals. This Gimli page shows the latest available ROSSARI price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹437.95
1W return
-2.57%
1M return
-11.69%
3M return
-17.94%
6M return
+2.17%
1Y return
-32.23%
Market cap
₹2,425.88 cr
PE
16.10
PB
1.82
ROE
+11.97%
ROCE
+11.48%
RSI
26.15
Turnover
₹2.54 cr
Why it can matter in screens
- Momentum: ROSSARI is below 50DMA, below 200DMA; RSI is 26.15.
- Returns: 1D -0.64%, 1W -2.57%, 1M -11.69%, 3M -17.94%, 1Y -32.23%.
- Trend levels: 52W high ₹575.00, 52W low ₹428.30, off high -23.83%.
- Liquidity: latest turnover is ₹2.54 cr; volume vs 20D is +0.79%.
- Valuation/profitability: PE 16.10, PB 1.82, ROE +11.97%, ROCE +11.48%.
- Growth: 3Y sales CAGR +13.21%, 3Y profit CAGR +11.63%.
Quick Answers
Is ROSSARI above its 50DMA and 200DMA?
ROSSARI is below 50DMA, below 200DMA. The latest 50DMA is 494.27 and the latest 200DMA is 511.87.
What are ROSSARI PE, ROE and ROCE?
ROSSARI has PE 16.10, ROE +11.97%, and ROCE +11.48% in Gimli's latest available snapshot.
How has ROSSARI performed recently?
ROSSARI has returned -11.69% over 1 month, -17.94% over 3 months, and -32.23% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 697.20 cr | 84.26 cr | 35.09 cr | 6.34 |
| 2026-03-31 | 684.86 cr | 96.83 cr | 45.97 cr | 8.30 |
| 2025-12-31 | 581.68 cr | 69.78 cr | 32.77 cr | 5.92 |
| 2025-09-30 | 587.71 cr | 73.53 cr | 36.88 cr | 6.65 |
| 2025-06-30 | 543.72 cr | 69.58 cr | 33.60 cr | 6.07 |
| 2025-03-31 | 579.56 cr | 71.43 cr | 34.44 cr | 6.22 |
| 2024-12-31 | 512.73 cr | 65.64 cr | 31.70 cr | 5.73 |
| 2024-09-30 | 498.35 cr | 66.95 cr | 35.33 cr | 6.39 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 2,396.36 cr | 310.18 cr | 149.21 cr | 26.95 |
| 2025-03-31 | 2,080.29 cr | 270.07 cr | 136.38 cr | 24.66 |
| 2024-03-31 | 1,825.19 cr | 257.38 cr | 130.69 cr | 23.67 |
| 2023-03-31 | 1,651.32 cr | 229.47 cr | 107.26 cr | 19.46 |
| 2022-03-31 | 1,085.54 cr | 196.99 cr | 79.47 cr | 17.81 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 2,288.79 cr | 75.31 cr | 435.94 cr | 1,333.35 cr |
| 2025-03-31 | 1,896.18 cr | 44.20 cr | 218.00 cr | 1,185.45 cr |
| 2024-03-31 | 1,572.15 cr | 25.17 cr | 118.79 cr | 1,047.73 cr |
| 2023-03-31 | 1,367.57 cr | 69.20 cr | 73.93 cr | 915.17 cr |
| 2022-03-31 | 1,256.72 cr | 37.48 cr | 8.43 cr | 805.16 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 65.07 cr | -199.60 cr | n/a |
| 2025-03-31 | 137.44 cr | -21.07 cr | n/a |
| 2024-03-31 | 43.26 cr | -88.03 cr | n/a |
| 2023-03-31 | 151.56 cr | 118.68 cr | n/a |
| 2022-03-31 | 29.36 cr | -8.87 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +68.14% | +2.02% | +14.64% | +9.77% | +15.20% | +0.00% |
| 2026-03-31 | +68.15% | +2.18% | +18.20% | +13.38% | +11.46% | +0.00% |
| 2025-12-31 | +68.16% | +2.33% | +18.26% | +13.47% | +11.26% | +0.00% |
| 2025-09-30 | +68.17% | +2.69% | +18.18% | +13.27% | +10.95% | +0.00% |
| 2025-06-30 | +68.17% | +3.48% | +17.84% | +13.42% | +10.51% | +0.00% |
| 2025-03-31 | +68.18% | +3.98% | +17.59% | +13.29% | +10.25% | +0.00% |
| 2024-12-31 | +68.19% | +3.74% | +17.47% | +13.25% | +10.60% | +0.00% |
| 2024-09-30 | +68.27% | +3.74% | +17.34% | +13.18% | +10.65% | +0.00% |
| 2024-06-30 | +68.32% | +3.83% | +16.87% | +12.96% | +10.98% | +0.00% |
| 2024-03-31 | +68.32% | +4.03% | +17.75% | +13.27% | +9.90% | +0.00% |
| 2023-12-31 | +68.33% | +4.14% | +18.06% | +13.93% | +9.46% | +0.00% |
| 2023-09-30 | +68.35% | +5.75% | +17.68% | +14.45% | +8.23% | +0.00% |
| 2023-06-30 | +68.43% | +6.12% | +17.71% | +15.40% | +7.73% | +0.00% |
| 2023-03-31 | +68.43% | +7.46% | +15.09% | +13.08% | +9.01% | +0.00% |
| 2022-12-31 | +68.44% | +8.63% | +14.08% | +12.64% | +8.85% | +0.00% |
| 2022-09-30 | +68.46% | +8.84% | +14.15% | +12.70% | +8.54% | +0.00% |
| 2022-06-30 | +68.56% | +0.00% | +21.53% | n/a | n/a | +0.00% |
| 2022-03-31 | +68.56% | +0.00% | +21.32% | n/a | n/a | +0.00% |
| 2021-12-31 | +68.56% | +0.00% | +21.90% | n/a | n/a | n/a |
| 2021-09-30 | +68.56% | +0.00% | +21.33% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SOLARINDS | SOLAR INDUSTRIES (I) LTD | 167,904.38 cr | 84.314744 | +35.93% | +26.94% |
| PIDILITIND | PIDILITE INDUSTRIES LTD | 160,004.45 cr | 60.281452 | +25.27% | +2.95% |
| SRF | SRF LTD | 74,457.19 cr | 34.443333 | +16.21% | -14.49% |
| COROMANDEL | COROMANDEL INTERNTL. LTD | 58,928.92 cr | 32.377284 | +14.95% | -13.24% |
| LINDEINDIA | LINDE INDIA LIMITED | 53,230.13 cr | 96.965414 | +13.58% | -3.17% |
| FLUOROCHEM | GUJARAT FLUOROCHEM LTD | 50,384.90 cr | 87.171106 | +7.60% | +23.51% |
| FACT | FACT LTD | 49,449.24 cr | -1248.718238 | -2.91% | -22.73% |
| UPL | UPL LIMITED | 48,961.82 cr | 23.550659 | +5.26% | -17.02% |
Try these prompts
- Analyze ROSSARI BIOTECH with valuation, momentum and industry peers
- Compare ROSSARI with other Chemicals stocks
- Show small-cap stocks in Chemicals above 50DMA with positive 1M return
- Find Chemicals stocks with improving momentum and reasonable valuation
Related screen ideas
- View Chemicals stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare ROSSARI with other Chemicals stocks
Data snapshot: 2026-09-18. Not investment advice.